Jack W. Lasersohn, Director at OncoMed Pharmaceuticals Inc (OMED), bought 1,045 shares at $17.00 ($18K) on 2014-08-15, disclosed to the SEC on 2014-08-19.
Open-market purchase of $18k OMED by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| OMED | BUY | 2017-05-25 | $71K | — | Filing → |
| OMED | BUY | 2017-05-18 | $164K | — | Filing → |
| OMED | BUY | 2015-10-01 | $180K | — | Filing → |